Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan.

Tsutomu TakeuchiYoshiya TanakaSakae TanakaAtsushi KawakamiYeong-Wook SongYi-Hsing ChenMitsuhiro RokudaHiroyuki IzutsuSatoshi UshijimaYuichiro KanekoYoshihiro NakashimaTeruaki ShiomiEmi Yamada

Published in: Arthritis research & therapy (2020)

ClinicalTrials.gov, NCT01638013, registered retrospectively 11 July 2012.

Keyphrases

open label
systematic review
electronic health record
big data
phase ii
combination therapy
radiation therapy
machine learning
deep learning
phase iii
data analysis
double blind